Plasma selenium level before diagnosis and the risk of prostate cancer development.

@article{Brooks2001PlasmaSL,
  title={Plasma selenium level before diagnosis and the risk of prostate cancer development.},
  author={James D Brooks and E. Jeffrey Metter and Daniel Wai-Tin Chan and Lori Sokoll and Patricia B Landis and William Andrew Nelson and Denis Muller and Reubin Andres and H Ballantine Carter},
  journal={The Journal of urology},
  year={2001},
  volume={166 6},
  pages={2034-8}
}
PURPOSE Epidemiological studies and a randomized intervention trial suggest that the risk of prostate cancer may be reduced by selenium intake. We investigated whether plasma selenium level before diagnosis correlated with the risk of later developing prostate cancer. MATERIALS AND METHODS A case control study was performed on men from the Baltimore Longitudinal Study of Aging registry, including 52 with known prostate cancer and 96 age matched controls with no detectable prostatic disease… CONTINUE READING